Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model

MLA

Yanan Wang, et al. “Chemokine Receptor CCR2b Enhanced Anti-Tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-Small-Cell Lung Carcinoma Model.” Frontiers in Immunology, vol. 12, Mar. 2021. EBSCOhost, https://doi.org/10.3389/fimmu.2021.628906.

APA

Yanan Wang, Jing Wang, Xinyi Yang, Jinlong Yang, Panpan Lu, Lin Zhao, Bokang Li, Hanyu Pan, Zhengtao Jiang, Xiaoting Shen, Zhiming Liang, Yue Liang, & Huanzhang Zhu. (2021). Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.628906

Chicago

Yanan Wang, Jing Wang, Xinyi Yang, Jinlong Yang, Panpan Lu, Lin Zhao, Bokang Li, et al. 2021. “Chemokine Receptor CCR2b Enhanced Anti-Tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-Small-Cell Lung Carcinoma Model.” Frontiers in Immunology 12 (March). doi:10.3389/fimmu.2021.628906.